“Some times I get up and can’t consider how far we’ve appear,” explained Dr. Doblin, 67, who now oversees the Multidisciplinary Association for Psychedelic Studies, a multimillion dollar exploration and advocacy empire that employs 130 neuroscientists, pharmacologists and regulatory specialists Func